ConductScience.org, home

Paper39772007

Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions.

Hsiung KC and 3 others. Vaccines (Basel), 2024. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions. Papers, record 39772007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39772007

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.85, provisional
iCite
Revised in PubMed
2025-01-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hsiung KCKuei-Ching
2Chiang HJHuan-Jung
3Reinig SSebastian
4Shih SRShin-Ru

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CORPD1J0061-63Chang Gung Memorial HospitalPubMed

Source PubMed

Download CSV of grants

References252

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120610717T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice.J Virol2010https://conductscience.org/library/papers/20610717PubMed
231067370Transmission of Nipah Virus - 14 Years of Investigations in Bangladesh.N Engl J Med2019https://conductscience.org/library/papers/31067370PubMed
33166919Pulmonary epithelial permeability in bronchiectasis.Br J Dis Chest1988https://conductscience.org/library/papers/3166919PubMed
434276608Altering Compositional Properties of Viral Genomes to Design Live-Attenuated Vaccines.Front Microbiol2021https://conductscience.org/library/papers/34276608PubMed
532075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
626752261PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.Hum Vaccin Immunother2016https://conductscience.org/library/papers/26752261PubMed
716111635Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.Immunity2005https://conductscience.org/library/papers/16111635PubMed
89655482Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.Immunity1998https://conductscience.org/library/papers/9655482PubMed
936560560mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics.Vaccines (Basel)2022https://conductscience.org/library/papers/36560560PubMed
1035343760Molecular Virology of SARS-CoV-2 and Related Coronaviruses.Microbiol Mol Biol Rev2022https://conductscience.org/library/papers/35343760PubMed
1136106872Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.J Virol2022https://conductscience.org/library/papers/36106872PubMed
1211337471The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403.Genome Res2001https://conductscience.org/library/papers/11337471PubMed
1332456079N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.Vaccines (Basel)2020https://conductscience.org/library/papers/32456079PubMed
1433824489Emerging concepts in the science of vaccine adjuvants.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33824489PubMed
1521576510Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study.J Immunol2011https://conductscience.org/library/papers/21576510PubMed
1618797453Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.Mol Ther2008https://conductscience.org/library/papers/18797453PubMed
1736118203Viral vector and nucleic acid vaccines against COVID-19: A narrative review.Front Microbiol2022https://conductscience.org/library/papers/36118203PubMed
1823806514Protective and dysregulated T cell immunity in RSV infection.Curr Opin Virol2013https://conductscience.org/library/papers/23806514PubMed
1918288193Global trends in emerging infectious diseases.Nature2008https://conductscience.org/library/papers/18288193PubMed
2033321075Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets.Cell Syst2021https://conductscience.org/library/papers/33321075PubMed

See all 252 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42797601Research Progress, Application, and Industrialization Prospects of Circular RNA Vaccines in Viral Diseases.Vaccines (Basel)2026https://conductscience.org/library/papers/42797601PubMed
42781491Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV.iScience2026https://conductscience.org/library/papers/42781491PubMed
41999993From legacy to innovation: A comprehensive review of vaccine platforms against viral infections.Virus Res2026https://conductscience.org/library/papers/41999993PubMed
41600980Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines.Vaccines (Basel)2026https://conductscience.org/library/papers/41600980PubMed
41425583Next-generation vaccines against bacterial pathogens: mRNA and beyond.Front Immunol2025https://conductscience.org/library/papers/41425583PubMed
41341596Heterologous ORFV-Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spike.Front Immunol2025https://conductscience.org/library/papers/41341596PubMed
41025086Recent advances in avian influenza virus: Molecular pathogenesis, emerging strains, and next-generation therapeutics.World J Virol2025https://conductscience.org/library/papers/41025086PubMed
40872886Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination.Vaccines (Basel)2025https://conductscience.org/library/papers/40872886PubMed
40144393mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/40144393PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39772007

GET https://conductscience.org/api/papers/v1/39772007/references?page=2